Ambu AS (FRA:547) Other Stockholders Equity: €14.4 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:547 Ambu AS FRA:547
87 GF Score
Price €15.90
GF Value €29.71
View Full Analysis

What is Ambu AS Other Stockholders Equity?

Ambu AS FRA:547 87 Other Stockholders Equity is €14.4 Mil as of Mar. 2026. GuruFocus rates FRA:547 with a GF Score™ of 87/100 and a GF Value™ of €29.71.

Ambu AS's Other Stockholders Equity for the quarter that ended in Mar. 2026 was €14.4 Mil.

Ambu AS's quarterly Other Stockholders Equity increased from Sep. 2025 (€4.8 Mil) to Dec. 2025 (€8.0 Mil) and increased from Dec. 2025 (€8.0 Mil) to Mar. 2026 (€14.4 Mil).

Ambu AS's annual Other Stockholders Equity declined from Sep. 2023 (€28.3 Mil) to Sep. 2024 (€19.4 Mil) and declined from Sep. 2024 (€19.4 Mil) to Sep. 2025 (€4.8 Mil).

Ambu AS Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Ambu AS's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambu AS Other Stockholders Equity Chart

Ambu AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 514.12 555.18 28.29 19.45 4.82

Ambu AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.33 4.83 4.82 8.03 14.45
FRA:547
87GF Score
Ambu AS FRA:547
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambu AS Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €14.4 Mil mean?
Ambu AS (FRA:547) has a Other Stockholders Equity of €14.4 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Ambu AS and its competitors.
Is Ambu AS's Other Stockholders Equity too high?
Ambu AS's current Other Stockholders Equity is €14.4 Mil. Overall, Ambu AS has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's Other Stockholders Equity compare to ABT and SYK?
Ambu AS's Other Stockholders Equity of €14.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Ambu AS and its competitors. Ambu AS's current Other Stockholders Equity is €14.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Ambu AS (FRA:547) has a current Other Stockholders Equity of €14.4 Mil. The stock's GF Value™ is €29.71, compared to a current price of €15.90 — trading 46.5% below its estimated fair value. The current Other Stockholders Equity is €14.4 Mil. Ambu AS's overall GF Score™ is 87/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Ambu AS (FRA:547), the current Other Stockholders Equity is €14.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambu AS (FRA:547) Overvalued in 2026?

Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued. The current stock price of €15.90 is trading 46.5% below its estimated GF Value™ of €29.71.

Key valuation signals for FRA:547:

  • Other Stockholders Equity: €14.4 Mil
  • GF Value™: €29.71 vs. price of €15.90 (46.5% below fair value)
  • GF Score™: 87/100

No single metric tells the full story. See the FRA:547 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ambu AS Business Description

Address Baltorpbakken 13, Ballerup, DNK, DK-2750
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
87GF Score

Get the complete analysis for FRA:547

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.90
Price
€29.71
GF Value